Inactive Instrument

News Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 09	Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing	MT
Apr. 05	Sector Update: Health Care Stocks Rise Friday Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics to Announce First Quarter Results on May 8, 2024	Apr. 24	AQ
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress	Apr. 10	AQ
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing	Apr. 09	MT
Sector Update: Health Care Stocks Rise Friday Afternoon	Apr. 05	MT
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	Apr. 05	MT
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session	Apr. 05	AQ
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	Apr. 05	CI
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 02	AQ
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 01	AQ
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session	Mar. 25	AQ
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology	Mar. 17	CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 Health Care	Mar. 17	CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400	Mar. 17	CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600	Mar. 17	CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600 Health Care	Mar. 17	CI
Transcript : Cytokinetics, Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM	Mar. 13
Mizuho Securities Adjusts Price Target on Cytokinetics to $99 From $103, Maintains Buy Rating	Mar. 06	MT
Cytokinetics to Participate in March Investor Conferences	Mar. 04	AQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 01	AQ
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day	Feb. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

Summary

Filters